Pfizer Foundation Inc
Pfizer Foundation consistently expends more than annual revenue, drawing from substantial asset base.
EIN: 136083839 · New York, NY · Updated: 2026-03-28
| Metric | Value |
|---|---|
| Total Revenue | $29.1M |
| Total Expenses | $49.6M |
| Program Spending | 95% |
| Net Assets | $250.0M |
| Transparency Score | 90/100 |
Is Pfizer Foundation Inc Legit?
Appears Legitimate
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Pfizer Foundation Inc directs 95% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Pfizer Foundation Inc
Pfizer Foundation Inc (EIN: 136083839) is a nonprofit organization based in New York, NY. The organization reported total revenue of $29.1M and total assets of $255.3M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Pfizer Foundation Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Pfizer Foundation Inc is a large nonprofit that has been operating for 71 years, with 8 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 4.3%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $17.7M |
| Total Expenses | $49.6M |
| Surplus / Deficit | $-31,915,039 |
| Total Assets | $255.4M |
| Total Liabilities | $5.3M |
| Net Assets | $250.0M |
| Operating Margin | -180.5% |
| Debt-to-Asset Ratio | 2.1% |
| Months of Reserves | 61.8 months |
Financial Health Grade: B
In 2023, Pfizer Foundation Inc reported a deficit of $31.9M with expenses exceeding revenue, holds 61.8 months of operating reserves (strong position), has a debt-to-asset ratio of 2.1% (very low leverage).
Financial Trends
Over 8 years of filings (2011–2023), Pfizer Foundation Inc's revenue has grown at a compound annual growth rate (CAGR) of 4.3%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | -53.4% | -4.8% | -0.4% |
| 2022 | -35.9% | +73.9% | -15.6% |
| 2021 | +245.8% | -44.9% | +11.2% |
| 2020 | +23.9% | +83.8% | -5.8% |
| 2019 | +153.2% | +60.6% | +63.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 1955 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Pfizer Foundation Inc with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 5%
- programs: 95%
- fundraising: 0%
According to IRS 990 filings, Pfizer Foundation Inc allocates its expenses as follows: admin: 5%, programs: 95%, fundraising: 0%. With 95% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a deficit of $31.9M, with expenses exceeding revenue.
- Debt-to-asset ratio: 2.1%.
Executive Compensation Analysis
Executive compensation is reported as 0% across all available filings, indicating that officers are either uncompensated by the foundation or compensated by the parent company, Pfizer Inc., which is a positive sign for direct charitable spending.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Strengths
The following positive indicators were identified for Pfizer Foundation Inc:
- Strong program spending, often exceeding annual revenue, indicating commitment to mission.
- Substantial and stable asset base (over $250 million) provides long-term financial security.
- 0% reported officer compensation, suggesting highly efficient use of funds for charitable purposes.
- Consistent history of significant philanthropic activity over many years.
Frequently Asked Questions about Pfizer Foundation Inc
Is Pfizer Foundation Inc a legitimate charity?
Pfizer Foundation Inc (EIN: 136083839) is a registered tax-exempt nonprofit based in New York. Our AI analysis gives it a Mission Score of 90/100. It has 8 years of IRS 990 filings on record. Total revenue: $29.1M. No red flags identified. 4 strengths noted. Financial health grade: B.
How does Pfizer Foundation Inc spend its money?
Pfizer Foundation Inc directs 95% of its spending to programs and services. This exceeds the 65% industry benchmark.
Are donations to Pfizer Foundation Inc tax-deductible?
Pfizer Foundation Inc is registered as a tax-exempt nonprofit (EIN: 136083839). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Pfizer Foundation Inc located?
Pfizer Foundation Inc is headquartered in New York, New York and files with the IRS under EIN 136083839.
How many years of IRS 990 filings does Pfizer Foundation Inc have?
Pfizer Foundation Inc has 8 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $29.1M in total revenue.
Is Pfizer Foundation Inc. a good charity?
Based on the available data, the Pfizer Foundation Inc. appears to be a highly effective grant-making organization. Its consistent expenditure of funds, often exceeding annual revenue, demonstrates a commitment to deploying its substantial assets for its mission. The 0% officer compensation is a strong indicator of efficient resource allocation.
How does the foundation manage its finances given expenses often exceed revenue?
The foundation manages this by drawing from its significant asset base, which has consistently been over $250 million in recent years. This allows it to make substantial grants even in years where direct revenue is lower, ensuring a steady flow of philanthropic support.
What is the primary focus of the Pfizer Foundation's spending?
While specific program details are not provided in the summary data, the nature of a corporate foundation and the high proportion of expenses relative to revenue (suggesting grant-making) indicates a primary focus on programmatic activities, likely health-related or community support, aligning with its parent company's mission.
Are there any concerns about the foundation's long-term financial stability?
Given its substantial assets, which were $255,288,291 in the latest period and have been consistently high, the foundation appears to be financially stable. Its ability to sustain high levels of spending even when revenue fluctuates suggests a well-managed endowment.
Filing History
IRS 990 filing history for Pfizer Foundation Inc showing financial trends over 8 years of public records:
Over 8 years of IRS 990 filings (2011–2023), Pfizer Foundation Inc's revenue has grown by 66.6%, moving from $10.6M to $17.7M. Total assets increased by 24.5% over the same period, from $205.0M to $255.4M. Total functional expenses rose by 170.5%, from $18.3M to $49.6M. In its most recent filing year (2023), Pfizer Foundation Inc reported a deficit of $31.9M, with expenses exceeding revenue. The organization holds $5.3M in liabilities against $255.4M in assets (debt-to-asset ratio: 2.1%), resulting in net assets of $250.0M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $17.7M | $49.6M | $255.4M | $5.3M | — | — |
| 2022 | $37.9M | $52.1M | $256.4M | $3.1M | — | View 990 |
| 2021 | $59.2M | $30.0M | $303.7M | $4.1M | — | View 990 |
| 2020 | $17.1M | $54.4M | $273.1M | $4.6M | — | View 990 |
| 2019 | $13.8M | $29.6M | $290.0M | $4.3M | — | View 990 |
| 2013 | $5.5M | $18.4M | $177.7M | $1.2M | — | View 990 |
| 2012 | $14.5M | $21.4M | $191.5M | $1.7M | — | View 990 |
| 2011 | $10.6M | $18.3M | $205.0M | $12.0M | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $17.7M, expenses of $49.6M, and assets of $255.4M (revenue -53.4% year-over-year).
- 2022: Revenue of $37.9M, expenses of $52.1M, and assets of $256.4M (revenue -35.9% year-over-year).
- 2021: Revenue of $59.2M, expenses of $30.0M, and assets of $303.7M (revenue +245.8% year-over-year).
- 2020: Revenue of $17.1M, expenses of $54.4M, and assets of $273.1M (revenue +23.9% year-over-year).
- 2019: Revenue of $13.8M, expenses of $29.6M, and assets of $290.0M (revenue +153.2% year-over-year).
- 2013: Revenue of $5.5M, expenses of $18.4M, and assets of $177.7M (revenue -62.5% year-over-year).
- 2012: Revenue of $14.5M, expenses of $21.4M, and assets of $191.5M (revenue +37.0% year-over-year).
- 2011: Revenue of $10.6M, expenses of $18.3M, and assets of $205.0M.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Pfizer Foundation Inc:
Data Sources and Methodology
This transparency report for Pfizer Foundation Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.